Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Castanheira, M. Articles by Jones, R. N. Search for Related Content PubMed PubMed Citation Articles by Castanheira, M. Articles by Jones, R. N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2004, p. 2344-2345, Vol. 48, No. 6
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.6.2344-2345.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Emergence of the Extended-Spectrum ß-Lactamase GES-1 in a Pseudomonas aeruginosa Strain from Brazil: Report from the SENTRY Antimicrobial Surveillance Program

Top Letter References

 
The extended-spectrum ß-lactamase (ESBL) GES-1 was initially described from a Klebsiella pneumoniae strain in 1998 (5). Since then, two closely related enzymes, IBC-1 and GES-2, have also been described (4, 6). A GES-1-producing K. pneumoniae strain has been reported from a French hospital, although the patient had just been transferred from French Guiana, South America. bla_GES-1 has also been found in a Pseudomonas aeruginosa strain isolated in another French medical center (3) and in K. pneumoniae in Lisbon, Portugal (2).

The GES-1-producing P. aeruginosa, isolate 48-8896, was recovered from a 63-year-old female who had a hysterectomy (São Paulo, Brazil) and developed a wound infection while receiving ceftriaxone, amikacin, and metronidazole. Blood cultures were drawn and were positive for P. aeruginosa. Polymyxin B plus vancomycin was started empirically and the infection was eradicated, but the patient died after being hospitalized in the intensive care unit for 3 months. Isolate 48-8896 showed resistance to imipenem MIC, >8 µg/ml), meropenem (MIC, >8 µg/ml), ceftazidime (MIC, >16 µg/ml), cefepime (MIC, >16 µg/ml), piperacillin-tazobactam (MIC, >64 µg/ml), and all antimicrobial agents evaluated (including aminoglycosides and quinolones), except for polymyxin B (MIC, 1 µg/ml). Phenotypic detection of ESBL was determined to be positive using the (ceftazidime/ceftazidime-clavulanic acid and cefepime/cefepime-clavulanic acid) Etest strips (AB BIODISK, Solna, Sweden).

Since several ß-lactamase genes are part of gene cassettes that are class 1 integron mediated and most of them contain an aminoglycoside acetyltransferase gene cassette, primers located in the 5' conserved segment region (5'-CS) (5'-CCAAGCTCTCGGGTAACATC-3') and in the flanking region of the aacA4 gene cassette (5'-AACTTGCGAGCGATCCGATG-3') were used. PCR amplification and subsequent sequencing analyses of the 1,211-bp PCR product showed a bla_GES-1 in the first position of a class 1 integron (Fig. 1).

View larger version (27K): [in this window] [in a new window]

FIG. 1. Schematic representations of different blaGES-1-containing integrons (a, b, c). The location of the three G residues found in the P2 of P. aeruginosa 48-8896 is highlighted. The 59 bp are represented with black dots.

The integron harboring bla_GES-1 showed a similar adjacent and upstream context as described in the first report of GES-1 (K. pneumoniae ORI-1) (5). Beyond bla_GES-1 was intI1, encoding the integrase of a class 1 integron. Between bla_GES-1 and intI1 was an attI1 site and two promoters (P2 and P_ant). However, the P2 promoter appears to have an absence of three G residues, and the space between the –35 and –10 sequences is 14 bp (Fig. 1). The secondary promoter (P2) is created by the insertion of the three Gs, increasing the space between the –35 and –10 regions to 17 bp (1). This evidence suggests that P2 was probably not contributing to the transcription of bla_GES-1, as previously described in other integrons harboring this ESBL gene (3, 5). As determined in this study, beyond the bla_GES-1 integron lies a chloramphenicol-acetyltransferase gene cassette, catB8, followed by the 3'-CS region of the class 1 integron, which is unique among bla_GES-1 genes.

The detection of a GES-1-producing P. aeruginosa isolate in Latin America (Brazil) was a very worrisome finding, since it heralds the possibility for the emergence and future dissemination of new GES derivatives with broader spectrums of hydrolyses, such as the carbapenem-hydrolyzing enzyme GES-2 (6).

 
The SENTRY program was funded by an educational research grant from Bristol-Myers Squibb.

Top Letter References

 

1
1. Collis, C. M., and R. M. Hall. 1995. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob. Agents Chemother. 39:155-162.[Abstract]
2
2. Duarte, A., F. Boavida, F. Grosso, M. Correia, L. M. Lito, and J. M. Cristino. 2003. Outbreak of GES-1-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob. Agents Chemother. 47:1481-1482.[Free Full Text]
3
3. Dubois, V., L. Poirel, C. Marie, C. Arpin, P. Nordmann, and C. Quentin. 2002. Molecular characterization of a novel class 1 integron containing bla_GES-1 and a fused product of aac3-Ib/aac6'-Ib' gene cassettes in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:638-645.[Abstract/Free Full Text]
4
4. Giakkoupi, P., L. Tzouveleskis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2004. IBC-1, a novel integron-associated class A ß-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44:2247-2253.
5
5. Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum ß-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.[Abstract/Free Full Text]
6
6. Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A ß-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603.[Abstract/Free Full Text]

						Mariana Castanheira Rodrigo E. Mendes Timothy R. Walsh* Department of Pathology & Microbiology University of Bristol Bristol, United Kingdom Ana C. Gales Disciplina de Doencas Infecciosas e Parasitarias Universidade Federal de Sao Paulo Sao Paulo, Brazil Ronald N. Jones The JONES Group/JMI Laboratories North Liberty, Iowa
						* Phone: 44 117 928-7522, Fax: 44 117 928-7896, E-mail: t.r.walsh{at}bristol.ac.uk

---

Antimicrobial Agents and Chemotherapy, June 2004, p. 2344-2345, Vol. 48, No. 6
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.6.2344-2345.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Lister, P. D., Wolter, D. J., Hanson, N. D. (2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 22: 582-610 [Abstract] [Full Text]  
• Picao, R. C., Poirel, L., Gales, A. C., Nordmann, P. (2009). Diversity of {beta}-Lactamases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Isolates Causing Bloodstream Infections in Brazil. Antimicrob. Agents Chemother. 53: 3908-3913 [Abstract] [Full Text]  
• Strateva, T., Yordanov, D. (2009). Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-1148 [Abstract] [Full Text]  
• Poirel, L., Carrer, A., Pitout, J. D., Nordmann, P. (2009). Integron Mobilization Unit as a Source of Mobility of Antibiotic Resistance Genes. Antimicrob. Agents Chemother. 53: 2492-2498 [Abstract] [Full Text]  
• Henrichfreise, B., Wiegand, I., Pfister, W., Wiedemann, B. (2007). Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with Hypermutation. Antimicrob. Agents Chemother. 51: 4062-4070 [Abstract] [Full Text]  
• Walther-Rasmussen, J., Hoiby, N. (2007). Class A carbapenemases. J Antimicrob Chemother 60: 470-482 [Abstract] [Full Text]  
• Queenan, A. M., Bush, K. (2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev. 20: 440-458 [Abstract] [Full Text]  
• Poirel, L., Naas, T., Nordmann, P. (2006). Pyrosequencing as a Rapid Tool for Identification of GES-Type Extended-Spectrum {beta}-Lactamases.. J. Clin. Microbiol. 44: 3008-3011 [Abstract] [Full Text]  
• Wang, C., Cai, P., Chang, D., Mi, Z. (2006). A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum {beta}-lactamase. J Antimicrob Chemother 57: 1261-1262 [Full Text]  
• Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
• Poirel, L., Brinas, L., Fortineau, N., Nordmann, P. (2005). Integron-Encoded GES-Type Extended-Spectrum {beta}-Lactamase with Increased Activity toward Aztreonam in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 3593-3597 [Abstract] [Full Text]  
• Weldhagen, G. F. (2004). Rapid Detection and Sequence-Specific Differentiation of Extended-Spectrum {beta}-Lactamase GES-2 from Pseudomonas aeruginosa by Use of a Real-Time PCR Assay. Antimicrob. Agents Chemother. 48: 4059-4062 [Abstract] [Full Text]  

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Castanheira, M. Articles by Jones, R. N. Search for Related Content PubMed PubMed Citation Articles by Castanheira, M. Articles by Jones, R. N.